Atlas market file · Equity · United States
Dillard'S, Inc.DDS
- Last close
- 612.14
- Change
- -0.80%
- 96-bar range
- 503.06 – 639.16
- As of
- 7 Aug 2026
Dillard'S, Inc. is a retail-department stores issuer listed as DDS on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+70.92% over the window).
Source rail: Yahoo Finance chart API (DDS). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for DDS. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
Atlas Pro artifact
DDS Market Snapshot PDF
The latest snapshot audit passed. Atlas checks entitlement and evidence again when the PDF is requested.
Atlas Pro entitlement required. The release gate runs again when you request the file.
DDS public profile
Retail-department stores issuer. Dillard'S, Inc. is connected to current market context, cited company sources and its retained research file.
Dillard'S, Inc. trades as DDS on NYSE. Dillard'S, Inc. (DDS) has a latest verified close of 612.14, down 0.80%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files DDS under USA Stocks for browsing.
What changed for Dillard'S, Inc. today
Dillard's, Inc. (DDS) has just filed its latest quarterly report, revealing a robust revenue of $1.57 billion and a cash pile of $1.16 billion. The company's net income for the period ending 2026-05-02 was a healthy $250.6 million, with diluted earnings per share coming in at $16.04. These figures paint a picture of a company that's not just surviving but thriving in the competitive retail environment.
Dillard's operates as a department store chain, offering a wide range of products including clothing, accessories, shoes, cosmetics, and more. The company's exclusive brands, such as Belle by Badgley Mischka and Bogg Bag, are a significant draw for customers. Despite the rise of e-commerce, Dillard's has managed to maintain a strong presence with its brick-and-mortar stores and online platform, proving that it's not just a relic of the past but a retailer that's adapting to the future.
The latest SEC filings provide a detailed look into Dillard's financial health. With assets totaling $4.14 billion and stockholders' equity attributable to the parent at $2.03 billion, the company is in a strong position. The net cash provided by operating activities for the quarter was $364.0 million, indicating a healthy cash flow. Capital expenditures for the period were $17.2 million, showing a commitment to maintaining and improving its physical stores and infrastructure.
To get a better sense of Dillard's market performance, you can check out its chart on TradingView. This will give you a visual representation of the company's stock price trends and trading volume, helping you understand how the market is reacting to the latest financial results and news. For a deeper dive into the company's operations and customer service, you can visit Dillard's official website, where you'll find information on everything from order history to exclusive brands.
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
DDS technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on DDS
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep DDS research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
DDS FAQ
What is Dillard'S, Inc. (DDS)?Dillard'S, Inc. (DDS) has a latest verified close of 612.14, down 0.80%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed...
Dillard'S, Inc. (DDS) has a latest verified close of 612.14, down 0.80%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for DDS?Dillard'S, Inc. (DDS) has a latest verified close of 612.14, down 0.80%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks...
Dillard'S, Inc. (DDS) has a latest verified close of 612.14, down 0.80%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files DDS under USA Stocks for browsing.
How often is the DDS page updated?The DDS public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The DDS public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for DDS?The DDS file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:DDS. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...
The DDS file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:DDS. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on DDS?Yes. The workstation can open DDS, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open DDS, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this DDS page investment advice?No. The DDS page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The DDS page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
DDS
Equity · evidence first